Outcomes of intravascular brachytherapy for recurrent drug‐eluting in‐stent restenosis
Megaly M, Glogoza M, Xenogiannis I, Vemmou E, Nikolakopoulos I, Willson L, Monyak DJ, Sullivan P, Stanberry L, Sorajja P, Chavez I, Mooney M, Traverse J, Wang Y, Garcia S, Poulose A, Burke MN, Brilakis ES. Outcomes of intravascular brachytherapy for recurrent drug‐eluting in‐stent restenosis. Catheterization And Cardiovascular Interventions 2020, 97: 32-38. PMID: 31943747, DOI: 10.1002/ccd.28716.Peer-Reviewed Original ResearchConceptsTarget lesion failureTarget lesion revascularizationRecurrent DES-ISRAcute coronary syndromeVascular brachytherapyDrug-eluting stentsDES-ISRMyocardial infarctionLower incidenceInitial presentationStent restenosisIncidence of TLRHigher TLFUse of IVUSProportional hazards analysisTertiary care institutionIntravascular ultrasound guidanceLong-term outcomesLesion myocardial infarctionTarget-lesion myocardial infarctionLesion revascularizationCoronary syndromeLesion failureCardiac deathUltrasound guidance